Associations between intensive diabetes therapy and NMR-determined lipoprotein subclass profiles in type 1 diabetes[S]

Associations between intensive diabetes therapy and NMR-determined lipoprotein subclass profiles in type 1 diabetes[S]

Our objective is to define differences in circulating lipoprotein subclasses between intensive versus conventional management of type 1 diabetes during the randomization phase of the Diabetes Control and Complications Trial (DCCT). NMR-determined lipoprotein subclass profiles (NMR-LSPs), which estim...

Full description

Bibliographic Details
Main Authors:	Ying Zhang, Alicia J. Jenkins, Arpita Basu, Julie A. Stoner, Maria F. Lopes-Virella, Richard L. Klein, Timothy J. Lyons
Format:	Article
Language:	English
Published:	Elsevier 2016-02-01
Series:	Journal of Lipid Research
Subjects:	intensive diabetes treatment dyslipidemia atherosclerosis clinical trial high density lipoprotein low density lipoprotein
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520354663

Similar Items

Apolipoprotein Mimetic Peptides: An Emerging Therapy against Diabetic Inflammation and Dyslipidemia
by: Paul Wolkowicz, et al.
Published: (2021-04-01)

How realistic are the LDL-C targets in new dyslipidemia guidelines - is it possible to reach the targets?
by: Barış Güngör
Published: (2020-03-01)

Cysteamine Decreases Low‐Density Lipoprotein Oxidation, Causes Regression of Atherosclerosis, and Improves Liver and Muscle Function in Low‐Density Lipoprotein Receptor–Deficient Mice
by: Feroz Ahmad, et al.
Published: (2021-09-01)

Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology
by: Børge G. Nordestgaard, et al.
Published: (2016-11-01)

High density lipoproteins and atherosclerosis II /
by: International Symposium on High Density Lipoproteins and Atherosclerosis (2nd : 1988 : Maidstone, England), et al.
Published: (1989)

Identification of roles for H264, H306, H439, and H635 in acid-dependent lipoprotein release by the LDL receptor
by: Hongyun Dong, et al.
Published: (2017-02-01)

Definition of the immunogenic forms of modified human LDL recognized by human autoantibodies and by rabbit hyperimmune antibodies
by: Gabriel Virella, et al.
Published: (2004-10-01)

Cell-associated heparin-like molecules modulate the ability of LDL to regulate PCSK9 uptake[S]
by: Adri M. Galvan, et al.
Published: (2019-01-01)

Relationship between subclasses low-density lipoprotein and carotid plaque
by: Pan Zhanhai, et al.
Published: (2022-03-01)

Plasma levels of lipoprotein-associated phospholipase A2 are increased in patients with β-thalassemia
by: Alexandros D. Tselepis, et al.
Published: (2010-11-01)

The role of level and function of High Density Lipoprotein (HDL) in Cardiovascular Diseases
by: Malihe Aghasizadeh, et al.
Published: (2020-06-01)

Association of Lipid Profile with the Severity of Diabetic Retinopathy: A Cross-sectional Study
by: T Shakthiya, et al.
Published: (2025-02-01)

High-density lipoprotein subclasses and cardiovascular disease and mortality in type 2 diabetes: analysis from the Hong Kong Diabetes Biobank
by: Qiao Jin, et al.
Published: (2022-12-01)

Role of apolipoprotein C1 in lipoprotein metabolism, atherosclerosis and diabetes: a systematic review
by: Alexia Rouland, et al.
Published: (2022-12-01)

ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan
by: Katherine Olin-Lewis, et al.
Published: (2002-11-01)

Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?
by: Michael B. Boffa, et al.
Published: (2016-05-01)

The metabolism of lipoprotein (a): an ever-evolving story
by: Gissette Reyes-Soffer, et al.
Published: (2017-09-01)

The Significance of Lipoproteins in the Development of Obesity
by: Alexander Blagov, et al.
Published: (2024-03-01)

High-density lipoproteins : from basic biology to clinical aspects /
by: Fielding, Christopher J.
Published: (2007)

Lipoprotein apheresis to treat elevated lipoprotein (a)1
by: Elisa Waldmann, et al.
Published: (2016-10-01)

Influence of age and sex on levels of anti-oxidized LDL antibodies and anti-LDL immune complexes in the general population
by: Francisco J. Tinahones, et al.
Published: (2005-03-01)

Alternations of Lipoprotein Profiles in the Plasma as Biomarkers of Huntington’s Disease
by: Kuo-Hsuan Chang, et al.
Published: (2023-01-01)

Elevated lipoprotein(a) as a predictor for coronary events in older men
by: Francesca Bartoli-Leonard, et al.
Published: (2022-08-01)

Disruption of ldlr causes increased LDL-c and vascular lipid accumulation in a zebrafish model of hypercholesterolemia[S]
by: Elizabeth A. O'Hare, et al.
Published: (2014-11-01)

Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides
by: G.M. Anantharamaiah, et al.
Published: (2007-09-01)

The early years of lipoprotein research: from discovery to clinical application
by: Patty W. Siri-Tarino, et al.
Published: (2016-10-01)

Levels of atherogenic lipoproteins are unexpectedly reduced in interstitial fluid from type 2 diabetes patients[S]
by: Johanna Apro, et al.
Published: (2015-08-01)

Comparison of ten formulae for calculating low-density lipoprotein cholesterol with direct low-density lipoprotein cholesterol measurement
by: Suriyan S. Nair, et al.
Published: (2024-10-01)

Lipids and Lipoproteins in Health and Disease: Focus on Targeting Atherosclerosis
by: Chih-Kuo Lee, et al.
Published: (2021-08-01)

Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate diet
by: Nastaran Faghihnia, et al.
Published: (2010-11-01)

Serum Lipoprotein (a) as a Diagnostic Marker of Coronary Artery Disease: A Case-Control Study
by: M.M. Kavitha, et al.
Published: (2018-07-01)

Metabolic origins and clinical significance of LDL heterogeneity
by: Kaspar K. Berneis, et al.
Published: (2002-09-01)

Lipid profile of healthy women during normal pregnancy
by: Diareme Margarita, et al.
Published: (2009-01-01)

A genome-wide search for gene-by-obesity interaction loci of dyslipidemia in Koreans shows diverse genetic risk alleles
by: Moonil Kang, et al.
Published: (2019-12-01)

Measurment of rhesus monkey (Macaca mulatta) apolipoprotein B in serum by radioimmunoassay: comparison of immunoreactivities of rhesus and human low density lipoproteins
by: J B Karlin, et al.
Published: (1978-02-01)

Combined data from LDL composition and size measurement are compatible with a discoid particle shape
by: Tom Teerlink, et al.
Published: (2004-05-01)

The effect of high-dose simvastatin on triglyceride-rich lipoprotein metabolism in patients with type 2 diabetes mellitus
by: William L. Isley, et al.
Published: (2006-01-01)

Association of serum Metrnl levels and high-density lipoprotein cholesterol in patients with type 2 diabetes mellitus: a cross-sectional study
by: Chenxia Zhou, et al.
Published: (2024-10-01)

Situational Analysis of Low-density Lipoprotein Cholesterol Control and the Use of Statin Therapy in Diabetes Patients Treated in Community Hospitals in Nanjing, China
by: Xiao-Jun Ouyang, et al.
Published: (2018-01-01)

Assessing the performance of monocyte to high-density lipoprotein ratio for predicting ischemic stroke: insights from a population-based Chinese cohort
by: Hao-Yu Wang, et al.
Published: (2019-05-01)